Search is Powered by Google
Eczema / Psoriasis News

ETIPs - Electronic-Targeted Intervention For Psoriasis

Main Category: Eczema / Psoriasis
Also Included In: Dermatology
Article Date: 29 Nov 2008 - 1:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Psoriasis affects 2-3% of people in the UK and can create both physical and psychological distress. Psychological discomfort is made worse by the visible nature of the condition whereby some people avoid exposing their skin and avoid social activity due to embarrassment. The University of Manchester has embarked on a PAPAA (Psoriasis and Psoriatic Arthritis Alliance) funded study to help people manage psoriasis better. The research team includes skin and psychology experts Professor Chris Griffiths, Professor Nick Tarrier, Dr. Christine Bundy, Ms. Binder Kaur and Dr. Sandra Bucci.

The team has designed a program, known as eTIPs (electronic-Targeted Intervention for Psoriasis). This is a web-based programme for people with psoriasis which aims to reduce psychological distress and improve psoriasis, help with coping and managing psoriasis better, improve quality of life, and increase feelings of confidence and positive thinking. Participants will complete the web-based therapy over a six week period and will be required to complete questionnaires at 3 or 4 different time points (including a six month follow-up).

e-TIPs is offered to individuals diagnosed with plaque psoriasis, who are 16 years or over, have working knowledge of the English language, and have internet access. It will be delivered on-line so that it is widely available, and can reach out to individuals who may not wish to discuss psychological complaints face-to-face. Participants can take part at their own convenience and in the privacy of their own home, and can also work at their own pace.

This study which began recruiting people in the autumn 2008 will run until December 2009.

Look out for recruitment announcements via the PAPAA website (http://www.papaa.org ) and local newspapers, radio and clinics (in Manchester only).

About PAPAA

PAPAA was founded in 2007, as a joint venture between the Psoriatic Arthropathy Alliance (PAA) (Reg Charity No: 3055414), and the Psoriasis Support Trust (PST) (Reg Charity No: 1088359), with the aim of merging the original charities into a single entity, becoming a principle resource of information and help for people with psoriasis and psoriatic arthritis in the UK.

PAPAA




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
What is Psoriasis? What Causes Psoriasis?
08 Mar 2009
Psoriasis is a dry, scaly skin disorder. Doctors believe that it is genetic and is caused by the immune system being mistakenly "triggered", resulting in skin cells being produced too quickly...


Psoriasis Therapy image Psoriasis Therapy

Previous treatments for moderate to severe psoriasis have been known to produce many unwanted side effects. Learn how a new class of drugs called biologic therapy is now offering people with moderate to severe psoriasis new hope with fewer side effects...

Psoriasis Therapy image Psoriasis Therapy

Previous treatments for moderate to severe psoriasis have been known to produce many unwanted side effects. Learn how a new class of drugs called biologic therapy is now offering people with moderate to severe psoriasis new hope with fewer side effects...

View more videos...